Retinol in Cosmetics: Regulatory Tightening and Market Changes

  As one of the most clinically validated active ingredients in the anti-aging field, retinol is currently entering a critical phase of market restructuring. The global retinol market continues to grow, yet its application in cosmetics is being profoundly influenced by multiple factors. On one hand, new concentration limits introduced by the European Union in 2024 are forcing brands to adjust their product strategies. On the other hand, the rapid development of alternative ingredients and delivery technologies is opening new technological pathways for efficacy-driven skincare. At the same time, the supply of retinol is highly dependent on the oligopolistic vitamin A industry, creating inherent constraints for cosmetics companies in terms of bargaining power and supply stability. Against this backdrop, companies are pursuing differentiated development paths based on their respective resource endowments.

I. Market Overview

In terms of overall scale, the retinol market is a mature raw-materials industry characterized by steady growth. In 2026, the global retinol market is estimated at approximately $1.45 billion, and it is projected to reach about $1.72 billion by 2033, representing a compound annual growth rate (CAGR) of 4.3%.

Global Retinol Market Size, 2025-2030

From an application perspective, the cosmetics and personal care sector accounts for roughly 51% to 76% of global retinol demand. Looking at the market from the perspective of end products, beauty products containing retinol reached a market size of approximately $1.02 billion in 2025 and are expected to grow to $1.74 billion by 2034, corresponding to a CAGR of about 6.11%.

This disparity highlights an important structural feature: while the retinol raw-materials market itself is relatively limited in size, the beauty products enabled by retinol represent a much larger downstream market opportunity.

Global Retinol Beauty Products Market Size, 2021-2034

In regional distribution in 2025, North America accounted for about 34% of the global retinol skincare product market, followed by Asia-Pacific with 29% and Europe with 27%. Although the three major regions have relatively similar market shares, their growth dynamics differ significantly.

The Asia-Pacific region is gradually becoming the main driver of global market growth, as consumer acceptance and purchasing willingness toward retinol products continue to rise in China and Japan. North America maintains stable demand, while growth in Europe has slowed due to increasingly stringent regulations.

This contrasting growth trajectory—marked by deceleration in Western markets and accelerating momentum across Asia—is now fundamentally reshaping the global efficacy-driven skincare industry.

II. European Regulations Are Reshaping Retinol Product Strategies

One of the most significant variables currently affecting the retinol market comes from European regulatory policy. In 2024, the European Union adopted Regulation (EU) 2024/996, which introduced explicit concentration limits for vitamin A derivatives used in cosmetic products.

Under the regulation, the maximum permitted concentrations for substances such as retinol, retinyl acetate, and retinyl palmitate in cosmetics are set as follows: 0.05% (Retinol Equivalent) for body lotions and 0.3% for other leave-on or rinse-off products.

In addition, all cosmetics containing vitamin A derivatives must include the label:“Contains Vitamin A. Consider your daily intake before use.”

These restrictions are not based on direct toxicity of retinol itself. Rather, they stem from the European Scientific Committee on Consumer Safety (SCCS) assessment of overall vitamin A exposure. The SCCS concluded that some consumers may already be close to the safe upper intake level through food and dietary supplements, making it necessary to manage additional exposure from cosmetic products.

The regulation also includes a defined transition timeline, under which non-compliant products may no longer be placed on the EU market from November 2025, and all such products must be completely withdrawn by May 2027.

For skincare brands that rely heavily on high-concentration retinol products, this means that product strategies for the European market must be adjusted, and the policy may also influence similar regulatory approaches in other regions in the future.

III. Supply Chain: Structural Constraints of Cosmetic-Grade Retinol

Retinol is not a typical cosmetic ingredient that can be easily formulated at will. Its production depends on the broader vitamin A industrial chain, which has long been dominated by a small number of large chemical companies.

The global vitamin A supply is highly concentrated, with major producers including BASF, DSM-Firmenich, Zhejiang NHU, Zhejiang Medicine, and Kingdomway. European companies have historically held technological and branding advantages, while Chinese firms have gradually entered the global supply system through large-scale capacity expansion.

From a demand perspective, approximately 72% of global vitamin A consumption comes from the feed industry, while cosmetic-grade products account for only about 10%. This demand structure places the cosmetics industry in a relatively weak position within the supply chain.

Several structural implications follow:

First, because cosmetics companies purchase relatively small volumes, their bargaining power in raw-material procurement is limited.

Second, when demand fluctuates in the feed sector or when key intermediates—such as citral—experience supply shortages, cosmetic-grade orders are often given lower priority.

Third, the development of high-purity or customized retinol products typically requires deep collaboration with upstream suppliers, a relationship that not all companies are able to secure.

IV. Comparison of Corporate Strategies

Within the global vitamin A industry chain, BASF, DSM-Firmenich, and China's Zhejiang NHU all have the capacity to produce retinol. Yet their strategic positioning in the retinol and downstream markets differs significantly—specifically in how each company leverages this foundational raw material to move into higher-value applications.

BASF

BASF remains one of the core players in the global vitamin A supply system. The company operates a highly integrated vitamin production complex in Ludwigshafen, Germany, utilizing its well-known Verbund chemical integration model to coordinate upstream raw materials, intermediates, and downstream production.

In recent years, BASF has continued expanding its vitamin A-related capacity, with vitamin A acetate capacity reaching approximately 3,800 tons per year. These products are mainly supplied to the animal nutrition, food fortification, and pharmaceutical sectors.

In personal care, BASF does not focus solely on supplying raw materials. Instead, it integrates retinol into its Care Creations formulation solutions platform. To address the susceptibility of retinol to degradation due to light and oxygen, the company has developed technologies such as microencapsulation and antioxidant synergistic systems, improving its stability and formulation applicability. Therefore, its advantages primarily lie in its formulation technology and stabilization solutions.

DSM-Firmenich

DSM-Firmenich takes a strategy that places greater emphasis on transforming the vitamin A system into a high-value functional active-ingredient platform.

The company produces vitamin A products at its Sisseln facility in Switzerland and markets them globally under the Quali-A® brand for the nutrition and pharmaceutical sectors.

Compared with BASF, DSM-Firmenich focuses more strongly on building active-ingredient systems for skincare. It develops different dosage forms and derivatives so that vitamin A ingredients can be used across multiple applications.

For example, the company has developed technologies such as beadlets, microencapsulation, and stabilized dry-powder systems. These technologies were initially used in food and pharmaceutical applications and later extended into cosmetics, thereby increasing the added value of its products.

Zhejiang NHU

Chinese company Zhejiang NHU represents a scale-manufacturing-driven development pathway.

The company currently has annual vitamin A production capacity of about 8,000 tons, accounting for roughly 13% of global capacity, making it one of the world’s major vitamin producers.

Its core advantage lies in independent production of key intermediates. Zhejiang NHU is among the few Chinese companies capable of producing citral in-house, which is a critical upstream intermediate for vitamin A synthesis. By integrating this key step into its industrial chain, the company has secured strong capabilities in cost control and supply stability.

This integrated structure enables the company to provide standard-specification vitamin A and retinol raw materials at competitive prices.

V. Shifting Competitive Tracks: Alternative Ingredients and Technological Upgrades

The EU concentration limits have not eliminated retinol from the market, but they have fundamentally changed the way companies compete.

In the past, brands often emphasized higher retinol concentrations to strengthen efficacy claims. Under the evolving regulatory environment, however, companies are increasingly focusing on alternative ingredients and technological innovation.

5.1 The Rise of Alternative Ingredients

Retinal (retinaldehyde) is an intermediate within the vitamin A metabolic pathway, positioned between retinol and retinoic acid.

Compared with retinol, retinal undergoes a more efficient conversion process in the skin. Retinol must undergo two metabolic steps to become the active form, retinoic acid, whereas retinal requires only one step.

Research indicates that retinal’s biological activity is approximately 11 times that of retinol. As a result, 0.2% retinal can achieve anti-aging effects comparable to or even exceeding 1% retinol, while still remaining below the EU limit of 0.3%.

Bakuchiol, by contrast, is derived from plant extracts. It is a monoterpene phenol that can bind to retinoic acid receptors in skin cells, activating anti-aging signaling pathways similar to those of retinol but with significantly lower irritation potential.

Clinical studies show that 0.5% bakuchiol improves fine lines and skin firmness within 12 weeks, with results statistically comparable to 0.5% retinol, while demonstrating better tolerability.

Between 2023 and 2025, the use of bakuchiol in global skincare products tripled. In China, the ingredient was registered as a new cosmetic raw material in 2022, allowing a maximum usage level of 2% in leave-on products.

In addition, some professional skincare brands are adjusting their product structures by using derivatives such as retinyl propionate, which may not be subject to the same strict concentration limits in certain regulatory frameworks, allowing brands to maintain efficacy claims within compliant boundaries.

5.2 Deepening Technological Upgrades

For companies continuing to use retinol, the emphasis on concentration has gradually given way to a focus on release efficiency.

The molecular structure of retinol contains multiple conjugated double bonds, making it highly sensitive to light, oxygen, and high temperatures, which can easily lead to oxidative degradation. At the same time, high concentrations of retinol may also cause skin irritation.

As a result, the industry has increasingly adopted technologies such as microencapsulation, liposomal carriers, and polymer delivery systems in recent years. These delivery systems form a physical barrier that protects retinol from environmental degradation and control the release rate of active ingredients through sustained-release mechanisms, thereby reducing irritation while prolonging its efficacy.

With advances in encapsulation technology, low-concentration retinol products can now achieve stable and gentle anti-aging effects, thereby expanding the potential consumer base.

Recent research also suggests that retinol may serve not only as an active ingredient but also as a penetration enhancer within combination systems. For example, microfluidically prepared nanoparticles co-loading lutein and retinol can achieve pH-responsive release, enabling sustained release of active substances in the skin environment and improving bioavailability.

VI. Market Outlook

The retinol market is undergoing a structural transformation driven jointly by regulation, technological innovation, and industrial structure. Within this transition, three major trends are becoming increasingly clear.

Regulation is changing the competitive logic of efficacy-driven skincare

The EU’s concentration limits for vitamin A derivatives have not weakened retinol’s market position, but they have effectively ended the strategy of competing through ever-higher concentrations. Future differentiation among skincare brands will increasingly depend on conversion efficiency, delivery systems, and formulation synergy, rather than simply ingredient content.

Alternative ingredients and technological pathways are developing in parallel

Substitutes such as retinal and bakuchiol are rapidly entering the market, offering alternative mechanisms for anti-aging efficacy. At the same time, technologies such as microencapsulation and liposomal delivery are continuously improving the stability and tolerability of retinol, enabling it to remain effective even at lower concentrations.

The industrial supply chain ultimately shapes the competitive landscape

Given that retinol is highly dependent on the vitamin A industry, upstream companies are developing three differentiated paths based on their resources: technology-driven solutions, high-value-added platform construction, and large-scale manufacturing and cost advantages. This differentiation is driving market competition to evolve from simple raw material supply to multi-dimensional approaches including technology integration, platform extension, and cost control.